Title: microRNA Affinity Assay and Uses Thereof
Patent Number: 8,846,350
Filed: Oct. 18, 2010
Lead Inventor: Simon Spivack, Albert Einstein College of Medicine
Title: sVEGFR-2 and Its Role in Lymphangiogenesis Modulation
Patent Number: 8,846,386
Filed: Dec. 18, 2008
Lead Inventor: Jayakrishna Ambati, University of Kentucky
Title: Pharmaceutical Composition for Treating Cancer
Patent Number: 8,846,630
Filed: Nov. 1, 2010
Lead Inventor: Misun Won, Korea Research Institute of Bioscience and Biotechnology
Title: microRNA Compositions and Methods
Patent Number: 8,846,631
Filed: Nov. 1, 2010
Lead Inventor: Eric Marcusson, Regulus Therapeutics
Title: Nucleic Acids for Targeting Multiple Regions of the HCV Genome
Patent Number: 8,846,632
Filed: Nov. 1, 2010
Inventor: Linda Couto, Children's Hospital of Philadelphia
Title: RNA Interference-mediated Inhibition of Gene Expression using Chemically Modified Short Interfering Nucleic Acid
Patent Number: 8,846,894
Filed: Feb. 16, 2007
Inventor: James McSwiggen, Sirna Therapeutics (Alnylam Pharmaceuticals)
Title: Double-stranded RNA Molecules with Stability in Mammalian Body Fluid, Preparation and Application Thereof
Patent Number: 8,846,895
Filed: March 29, 2011
Inventor: Quan Du, Biomics Biotechnologies